Babson Diagnostics Closes $13.7 Million Series A to Democratize Diagnostic Blood Testing
AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics (Babson), a transformative medical technology company, announced today it closed $13.7 million in cumulative Series A...